Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy

This study has been completed.

Sponsor:

Information provided by:

Valeant Pharmaceuticals International, Inc.

ClinicalTrials.gov Identifier:

NCT00086541

First received: July 2, 2004

Last updated: May 3, 2007

Last verified: May 2007

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2007
Estimated Primary Completion Date:	No date given